These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24965963)

  • 1. Resistant hypertension in diabetes mellitus.
    Bayliss G; Weinrauch LA; D'Elia JA
    Curr Diab Rep; 2014 Aug; 14(8):516. PubMed ID: 24965963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, sleep apnea, aldosterone, and hypertension.
    Goodfriend TL
    Curr Hypertens Rep; 2008 Jun; 10(3):222-6. PubMed ID: 18765094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, kidney dysfunction and hypertension: mechanistic links.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Nat Rev Nephrol; 2019 Jun; 15(6):367-385. PubMed ID: 31015582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in sympathetic activity in obesity and its related hypertension.
    Fu Q
    Ann N Y Acad Sci; 2019 Oct; 1454(1):31-41. PubMed ID: 31087350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system.
    Daly PA; Landsberg L
    Diabetes Care; 1991 Mar; 14(3):240-8. PubMed ID: 2044439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
    Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
    Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural mechanisms and management of obesity-related hypertension.
    Esler MD; Eikelis N; Lambert E; Straznicky N
    Curr Cardiol Rep; 2008 Nov; 10(6):456-63. PubMed ID: 18950554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes.
    Boer-Martins L; Figueiredo VN; Demacq C; Martins LC; Faria AP; Moraes Cde H; Moreno H
    Arq Bras Cardiol; 2012 Jul; 99(1):642-8. PubMed ID: 22641394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.
    Chen W; Leo S; Weng C; Yang X; Wu Y; Tang X
    Herz; 2015 Apr; 40 Suppl 2():190-6. PubMed ID: 24609799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, sympathetic overdrive, and hypertension: the leptin connection.
    Rahmouni K
    Hypertension; 2010 Apr; 55(4):844-5. PubMed ID: 20194295
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of leptin and central nervous system melanocortins in obesity hypertension.
    da Silva AA; do Carmo JM; Hall JE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):135-40. PubMed ID: 23299052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic nervous system, diabetes, and hypertension.
    Perin PC; Maule S; Quadri R
    Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.
    Balasubramanian P; Hall D; Subramanian M
    Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin and hypertension in obesity.
    Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
    Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.
    Marcus JA; Pothineni A; Marcus CZ; Bisognano JD
    Curr Hypertens Rep; 2014 Jan; 16(1):411. PubMed ID: 24346827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sympathetic nervous system alterations in human hypertension.
    Grassi G; Mark A; Esler M
    Circ Res; 2015 Mar; 116(6):976-90. PubMed ID: 25767284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.